{"id":"W2975423547","doi":"10.1001/jamacardio.2019.3355","title":"Benefit and Risks of Aspirin in Addition to Ticagrelor in Acute Coronary Syndromes","year":2019,"lang":"en","type":"article","venue":"JAMA Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":134,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Abbott Vascular; Regeneron Pharmaceuticals; National Institutes of Health; Idorsia Pharmaceuticals; Daiichi Sankyo Europe; Gilead Sciences; Servier; Eisai; Osprey Medical; Daiichi-Sankyo; Medicines Company; AstraZeneca; Amarin Corporation; Ironwood Pharmaceuticals, Incorporated; Boston Scientific Corporation; Bristol-Myers Squibb; Eli Lilly and Company; Abbott Laboratories; CSL Behring; Pfizer; Amgen; Edwards Lifesciences; Sanofi; Medicure; American Heart Association","keywords":"Ticagrelor; Medicine; Aspirin; Percutaneous coronary intervention; Acute coronary syndrome; Conventional PCI; Clopidogrel; Internal medicine; Myocardial infarction; Coronary artery disease; Context (archaeology); Cardiology; Stroke (engine)","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"not_applicable","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low","status":"direct model label, unvalidated"},{"model":"gpt","categories":[],"domain":null,"study_design":"design_other","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low","status":"direct model label, unvalidated"}],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003193975,0.0005973781,0.0009319889,0.0003639639,0.0002264309,0.0005660132,0.0002927012,0.0009431312,0.001734248],"category_scores_gemma":[0.006654461,0.0002453802,0.001624763,0.0003497921,0.0005850774,0.0006767877,0.00038173,0.001003464,0.0001171163],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002289234,"about_ca_system_score_gemma":0.0004270155,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002382033,"about_ca_topic_score_gemma":0.0006984703,"domain_scores_codex":[0.9975312,0.001705123,0.0001708793,0.0001873146,0.0003022244,0.0001031507],"domain_scores_gemma":[0.9949316,0.003284267,0.001089364,0.000198149,0.0001382835,0.0003582465],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.5296876,0.003972293,0.3012602,0.002471931,0.01204526,0.0003836551,0.0002669042,0.0014671,0.0047506,0.0005447309,0.001055828,0.1420939],"study_design_scores_gemma":[0.09030292,0.1438914,0.726695,0.0006520593,0.02414831,0.0008967738,0.0003221777,0.003504669,0.002787839,0.002655623,0.004045534,0.00009769016],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9851812,0.01238948,0.0002543709,0.0007229543,0.00007895463,0.0001030702,0.0001609259,0.00000641709,0.001102685],"genre_scores_gemma":[0.9974292,0.001550219,0.000327313,0.0001785644,0.0002234209,0.00004082306,0.00008682896,0.000001176648,0.0001624445],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003193975,"threshold_uncertainty_score":0.01689154,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02400867189315251,"score_gpt":0.2933001685135623,"score_spread":0.2692914966204098,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}